RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 75 filers reported holding RECRO PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $130,000 | +271.4% | 46,770 | +278.4% | 0.00% | – |
Q4 2020 | $35,000 | -32.7% | 12,359 | -49.8% | 0.00% | – |
Q3 2020 | $52,000 | -53.6% | 24,627 | 0.0% | 0.00% | – |
Q2 2020 | $112,000 | -46.7% | 24,627 | +114.5% | 0.00% | – |
Q4 2019 | $210,000 | +32.9% | 11,481 | -19.4% | 0.00% | – |
Q3 2019 | $158,000 | -72.9% | 14,251 | -75.1% | 0.00% | – |
Q2 2019 | $582,000 | +9.0% | 57,179 | -37.3% | 0.00% | – |
Q1 2019 | $534,000 | -32.2% | 91,191 | -17.9% | 0.00% | – |
Q4 2018 | $788,000 | -1.4% | 111,047 | -1.2% | 0.00% | – |
Q3 2018 | $799,000 | +33.4% | 112,447 | -5.8% | 0.00% | – |
Q2 2018 | $599,000 | -56.2% | 119,399 | -3.8% | 0.00% | -100.0% |
Q1 2018 | $1,367,000 | +16.4% | 124,115 | -2.2% | 0.00% | – |
Q4 2017 | $1,174,000 | +0.9% | 126,954 | -2.0% | 0.00% | -100.0% |
Q3 2017 | $1,163,000 | +27.7% | 129,560 | 0.0% | 0.00% | – |
Q2 2017 | $911,000 | +611.7% | 129,560 | +787.4% | 0.00% | – |
Q1 2017 | $128,000 | +8.5% | 14,600 | 0.0% | 0.00% | – |
Q4 2016 | $118,000 | – | 14,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |